dihydrouracil has been researched along with Cancer of Stomach in 1 studies
hexahydropyrimidine-2,4-dione: structure in first source
5,6-dihydrouracil : A pyrimidine obtained by formal addition of hydrogen across the 5,6-position of uracil.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Twenty-five gastric cancer patients were administered UFT at 370 mg/m(2)/day for 21 days and cisplatin at 15 mg/m(2)/day for 2 days." | 2.70 | Dihydropyrimidine dehydrogenase-related enzymes predict efficacy and adverse reactions of UFT1+cisplatin neoadjuvant chemotherapy for gastric cancer. ( Ishii, R; Koda, K; Miyazaki, M; Oda, K; Ooshima, H; Suzuki, H; Takiguchi, N, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Takiguchi, N | 1 |
| Koda, K | 1 |
| Ooshima, H | 1 |
| Oda, K | 1 |
| Suzuki, H | 1 |
| Ishii, R | 1 |
| Miyazaki, M | 1 |
1 trial available for dihydrouracil and Cancer of Stomach
| Article | Year |
|---|---|
Dihydropyrimidine dehydrogenase-related enzymes predict efficacy and adverse reactions of UFT1+cisplatin neoadjuvant chemotherapy for gastric cancer.
Topics: Amidohydrolases; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; | 2002 |